Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Audientes – Presentation of Q3 2024 report

By Michael FriisHead of Equities
Audientes

You can already now sign up for the event and send in your questions. You don’t have to participate live to submit questions for the event.

Audientes expects to release its Q3 2024 results on 21 November 2024. Audientes’ CEO Steen Thygesen will present the results, provide a business update, and answer questions at an online live event on 22 November 2024 at 11:00.

Since the H1 2024 report, Audientes has announced news regarding the capital situation and funding journey. The company has agreed with existing lenders to postpone payments of DKK 2.3m into 2025 and a direct issue with both new cash and conversion of debt of DKK 1.7m to deliver on the opportunities the company is experiencing. Additionally, Audientes has also initiated a consumer marketing & sales campaign targeting Japan's large "Silver Market". Besides the financial results, the focus could be on comments about the market launches in Japan and China as well as the capital situation.

Audientes is a Danish hearing health company specializing in smart, self-fitting affordable hearing aids and advanced hearables. Audientes’ unique hearing aid solution, Ven™ by Audientes, is available for purchase in the Indian and Nepalese markets and is expected to be introduced in other markets in the coming years.

Disclaimer: HC Andersen Capital receives payment from Audientes for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 09.07, 4 November 2024.

Recent videos

HCA 2025 forudsigelser - Ramte lidt uden for skiven
16.12.2025, 11.11 Ørsted
HCA Morgenbørs 16/12 - Vi ser ind i et røde europæiske futures, dog delvist beskyttet af mindre tech eksponering
16.12.2025, 09.15 Scandinavian Medical Solutions
Life Science Companies as Investments | Life Science Night Dec. 9, 2025
16.12.2025, 08.30 Aiforia Technologies
Truecaller, Webcast, Press Conference, 2025
15.12.2025, 13.00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
15.12.2025, 13.00 Herantis Pharma
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.